Patent · US Active

Antisense compositions and methods of making and using same

US10272047B2 · kind B2 · utility

4Cited by

25References

23Claims

0Family size

Assignee

Nogra Pharma Limited · IE

Inventors

Sergio Baroni · Rossera, IT
Salvatore Bellinvia · Balerna, CH
Francesca Viti · Salorino, CH

Key dates

Filing date	Oct 26, 2016
Grant date	Apr 30, 2019
Priority date	—
Expiry date	Oct 26, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides pharmaceutical formulations for oral administration of antisense oligonucleotides, such as antisense oligonucleotides against SMAD7. The pharmaceutical formulations can be used to treat Crohn's disease, ulcerative colitis and chronic inflammatory bowel disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.